Rocksauce Fire

Description

The product is identified by SPL Code 34089-3 and is presented as a white to off-white powder. Its chemical name is insert chemical name here. The formulation includes inactive ingredients such as insert inactive ingredients here.

Uses and Indications

This drug is indicated for the temporary relief of minor muscular discomfort.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For the temporary relief of minor muscular discomfort, the lotion should be applied liberally to the affected area. The application should be followed by gentle massage until the lotion is fully absorbed into the skin. This process may be repeated 3 to 4 times daily, as needed.

It is important to note that this product is not intended for use in children aged 5 years or younger.

The lotion should be stored at a temperature range of 68 to 77°F (20 to 25°C) to maintain its efficacy.

Contraindications

Use is contraindicated in the following situations:

Heating, microwaving, or adding to hot water or any container where heating may cause splattering is contraindicated due to the risk of burns. Application to the eyes or directly on mucous membranes is prohibited to prevent irritation or injury. Ingestion by mouth or placement in the nostril is contraindicated to avoid potential toxicity. Application to wounds or damaged skin is not recommended to prevent adverse reactions. Additionally, use should strictly adhere to the provided directions to ensure safety and efficacy.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, mucous membranes, or broken skin to prevent adverse reactions.

In the event of accidental ingestion, immediate medical assistance should be sought. Healthcare professionals are advised to contact a Poison Control Center without delay to ensure appropriate management.

Patients should discontinue use and consult their healthcare provider if symptoms persist for more than one week or if they recur. Continuous monitoring of the patient's condition is essential to determine the need for further intervention.

Side Effects

Patients should be aware that the product is intended for external use only. It is crucial to avoid contact with the eyes, mucous membranes, or broken skin to prevent potential adverse reactions.

In the event that symptoms persist for more than one week or recur, patients are advised to consult a doctor and discontinue use. This precaution is essential to ensure safety and to address any underlying conditions that may require medical attention.

Drug Interactions

No specific drug interactions have been identified for the product. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Rocksauce Fire (methyl salicylate, menthol and capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 5 years of age should not use this medication. Safety and efficacy have not been established in this age group, and caution is advised when considering treatment options for younger children.

Geriatric Use

Elderly patients should be aware that this medication is not indicated for use in children aged 5 years or younger. It is essential for geriatric patients to consult a healthcare provider if their condition persists for more than one week or if symptoms recur. Discontinuation of the medication may be necessary under these circumstances, and ongoing monitoring by a healthcare professional is advised to ensure safety and efficacy in this population.

Pregnancy

There is no information available regarding the use of ROCKSAUCE FIRE (methyl salicylate, menthol, and capsaicin cream) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and during pregnancy, given the lack of data on potential fetal impacts. It is advisable to weigh the benefits against any unknown risks when recommending this product to pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may include maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

Healthcare professionals should also consider contacting a poison control center for guidance on specific interventions and treatment protocols tailored to the substance involved in the overdose.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is accidentally ingested. It is important for patients to consult their doctor and discontinue use if their condition persists for more than one week or if it recurs.

Providers should instruct patients not to heat, microwave, or add the product to hot water or any container that may cause splattering, as this could result in burns. Additionally, patients should be cautioned against using the product in or around the eyes, on mucous membranes, by mouth, or in the nostrils.

Patients must also be informed not to apply the product to wounds or damaged skin. Emphasizing the importance of following directions, healthcare providers should remind patients not to use the product in any manner other than as directed.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68 to 77°F (20 to 25°C) to maintain its integrity and effectiveness.

Care should be taken to avoid heating the product; it must not be heated, microwaved, or placed in hot water. Additionally, it should not be stored in any container that may cause heating water to splatter, as this could result in burns. Proper handling and storage conditions are crucial to ensure the safety and efficacy of the product.

Additional Clinical Information

The medication is administered topically, with patients advised to apply it liberally to the painful area and massage until absorbed into the skin. This process may be repeated 3-4 times daily.

Clinicians should counsel patients that the product is for external use only and must be kept away from the eyes, mucous membranes, and broken skin. It should also be stored out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. If symptoms persist for more than one week or recur, patients are advised to consult a doctor and discontinue use.

Drug Information (PDF)

This file contains official product information for Rocksauce Fire, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)